Corbus Pharmaceuticals Holdings Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Corbus Pharmaceuticals Holdings Inc
TickerCRBP
CIK #0001595097
CUSIP21833P301
SectorLife Sciences - Pharmaceutical Preparations
Address100 River Ridge Drive, Norwood, MA 02062
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Corbus Pharmaceuticals Holdings Inc 2014-04-23 6.3 M Exemption: 506(b) · Remaining: $6,690,000 · Duration: One year or less · Commission: $1,300,000 · Revenue: Decline to Disclose
SAV Acquisition Corp 2014-01-10 0.1 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001595097] 10-K
[0001595097] 10-Q
[0001595097] 3
[0001595097] 4
[0001595097] 5
[0001595097] 8-K
[0001595097] D
[0001595097] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Aberdeen Group PLC Corbus Pharmaceuticals Holdings Inc [2026-01-16] 0.0
Citadel Advisors LLC Corbus Pharmaceuticals Holdings Inc [2025-11-12] 0.0
OrbiMed Advisors LLC Corbus Pharmaceuticals Holdings Inc [2024-11-14] 2.7
BlackRock Inc Corbus Pharmaceuticals Holdings Inc [2024-11-08] 6.7
BlackRock Inc Corbus Pharmaceuticals Holdings Inc [2024-10-22] 6.7
Octagon Capital Advisors LP Corbus Pharmaceuticals Holdings Inc [2024-10-11] 0.3
Millennium Management LLC Corbus Pharmaceuticals Holdings Inc [2024-02-28] 5.3
Paradigm Biocapital Advisors LP Corbus Pharmaceuticals Holdings Inc [2024-02-14] 0.0
K2 Healthventures Equity Trust LLC Corbus Pharmaceuticals Holdings Inc [2024-02-14] 7.8
RA Capital Management LP Corbus Pharmaceuticals Holdings Inc [2024-02-12] 4.1
Adage Capital Partners GP LLC Corbus Pharmaceuticals Holdings Inc [2024-02-12] 7.7
Integrated Core Strategies US LLC Corbus Pharmaceuticals Holdings Inc [2024-02-09] 4.0
Cormorant Global Healthcare Master Fund LP Corbus Pharmaceuticals Holdings Inc [2024-02-05] 14.27
Paradigm Biocapital Advisors LP Corbus Pharmaceuticals Holdings Inc [2024-02-05] 0.0
Point72 Asset Management LP Corbus Pharmaceuticals Holdings Inc [2024-01-29] 8.8
Tang Capital Partners LP Corbus Pharmaceuticals Holdings Inc [2024-01-26] 9.6
ETF Managers Group LLC Corbus Pharmaceuticals Holdings Inc [2018-10-29] 7.28
BlackRock Inc Corbus Pharmaceuticals Holdings Inc [2018-02-01] 6.6
Cormorant Asset Management LLC Corbus Pharmaceuticals Holdings Inc [2016-09-29] 4.47
Knoll Capital Management LP Corbus Pharmaceuticals Holdings Inc [2016-03-01] 5.96
Knoll Capital Management LP Corbus Pharmaceuticals Holdings Inc [2015-08-05] 8.5
Stern Adam K Corbus Pharmaceuticals Holdings Inc [2015-07-29] 8.7
Burstein Sumner Corbus Pharmaceuticals Holdings Inc [2015-07-21] 14.8
Corbus Pharmaceuticals Holdings Inc Corbus Pharmaceuticals Holdings Inc [2015-02-17] 8.7
Tepper Mark Corbus Pharmaceuticals Holdings Inc [2015-02-17] 8.7
Form 3/4/5 Filer 2011 - 2026
SAV Acquisition Corp
Kung Winston
Altmeyer Anne
Jenkins John Kenneth
Saxena Nishant C
Jacques Rachelle Suzanne
Ben Yong
Pfeiffenberger Brent
Smethurst Dominic
Cohen Yuval
Hodgson Ian
Moran Sean F
Cormorant Global Healthcare Master Fund LP
Cormorant Asset Management LP
Chen Bihua
Holmer Alan F
Catlin Avery W
Salzmann Peter
Brake Rachael Louise
Millian Craig Stuart
White Barbara
Golumbeski George
Hochman David P
Discordia Robert Paul
Panayiotopoulos Paris
Tepper Mark
Gupta Renu
Burstein Sumner
Knoll Capital Management LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Smethurst Dominic
Common Stock, par value $0.0001 per share
2026-03-02 Sell 6,097 $8.30 50,605
Hodgson Ian
Common Stock, par value $0.0001 per share
2026-02-17 Sell 847 $7.38 6,251
Cohen Yuval
Common Stock, par value $0.0001 per share
2026-02-13 Sell 13,871 $7.78 107,916
Moran Sean F
Common Stock, par value $0.0001 per share
2026-02-13 Sell 4,701 $7.78 36,574
Smethurst Dominic
Common Stock, par value $0.0001 per share
2026-02-03 Sell 3,285 $8.09 26,576
Hodgson Ian
Common Stock, par value $0.0001 per share
2026-02-03 Sell 2,415 $8.09 19,537
Smethurst Dominic
Stock options (right to buy) · derivative
2026-01-14 Grant 85,095 $0.00
Cohen Yuval
Stock options (right to buy) · derivative
2026-01-14 Grant 150,000 $0.00
Hodgson Ian
Stock options (right to buy) · derivative
2026-01-14 Grant 85,095 $0.00
Smethurst Dominic
Common Stock, par value $0.0001 per share
2026-01-14 Grant 28,365 $0.00
Cohen Yuval
Common Stock, par value $0.0001 per share
2026-01-14 Grant 50,000 $0.00
Hodgson Ian
Common Stock, par value $0.0001 per share
2026-01-14 Grant 28,365 $0.00
Moran Sean F
Stock options (right to buy) · derivative
2026-01-14 Grant 84,247 $0.00
Moran Sean F
Common Stock, par value $0.0001 per share
2026-01-14 Grant 28,082 $0.00
Cormorant Global Healthcare Master Fund LP +2
Common Stock
2025-12-11 Sell 30,029 $11.46 344,132
Cohen Yuval
Stock options (right to buy) · derivative
2025-10-27 Option exercise 8,973 $0.00
Cohen Yuval
Common Stock, par value $0.0001 per share
2025-10-27 Sell 8,973 $17.14 153,797
Cohen Yuval
Common Stock, par value $0.0001 per share
2025-10-27 Option exercise 8,973 $4.26 38,225
Cohen Yuval
Common Stock, par value $0.0001 per share
2025-10-24 Option exercise 18,660 $4.26 79,492
Cohen Yuval
Stock options (right to buy) · derivative
2025-10-24 Option exercise 18,660 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 107 13,152,355
2025-12-31 100 13,300,811
2025-09-30 87 9,399,619
2025-06-30 82 9,108,101
2025-03-31 87 10,458,431
2024-12-31 101 11,553,954
2024-09-30 112 12,837,323
2024-06-30 108 10,398,626
2024-03-31 85 8,887,315
2023-12-31 36 786,470
2023-09-30 29 777,195
2023-06-30 30 773,837
Form 13F Holdings
Firm Period DFND Voting Shares
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 22,646 22,646
Versant Capital Management Inc [2026-06-30] SOLE 601 601
Gamma Investing LLC [2026-06-30] DFND 336 336
Spire Wealth Management [2026-06-30] SOLE 0 66
Corecap Advisors LLC [2026-06-30] SOLE 0 25
Eastern Bank [2026-06-30] SOLE 6 6
BFSG LLC [2026-06-30] SOLE 0 1
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com